Market Scope’s United States ophthalmic atlases identify treatment opportunity at the metro level for the top 85 metros—identifying high-opportunity and diseased populations, procedure volumes, premium penetration rates, surgeon counts, surgical locations, and much more. Companies often use this data throughout the development and commercialization processes to identify ideal clinical trial locations, develop launch strategies, define sales territories, allocate resources, and optimize sales and marketing initiatives.
Market Scope uses the proprietary MedOp Index™ Analysis to examine market potential and provides a benchmark against other metros. Each clinical area atlas considers multiple factors to identify opportunity. For example, the cataract MedOp Index™ considers the concentration of active, affluent seniors; the number of high-volume cataract surgeons; and ASC counts and volumes, while the retina MedOp Index™ considers annual IVT injections and vitrectomies per provider; the geographic concentration of diabetics; the total population with retinal diseases; and high-volume retinal care providers.
Contact us using the button below to request more information on atlas coverage, view a demo, or schedule a time to discuss this live with our team.
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.